Immediate Impact

5 from Science/Nature 67 hit
Sub-graph 1 of 22

Citing Papers

Hidradenitis suppurativa
2025 Hit
Encorafenib, cetuximab and chemotherapy in BRAF-mutant colorectal cancer: a randomized phase 3 trial
2025 Hit
2 intermediate papers

Works of Badi El Osta being referenced

Phase Ib study of vemurafenib in combination with irinotecan and cetuximab in patients with BRAF-mutated metastatic colorectal cancer and advanced cancers.
2015
Donepezil for Cancer Fatigue: A Double-Blind, Randomized, Placebo-Controlled Trial
2007

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Badi El Osta 620 435 371 289 207 33 1.2k
Matthias Weiss 831 1.3× 195 0.4× 220 0.6× 149 0.5× 148 0.7× 46 1.4k
Linda Sutton 476 0.8× 251 0.6× 188 0.5× 101 0.3× 131 0.6× 45 946
Monica Indelli 802 1.3× 738 1.7× 405 1.1× 186 0.6× 85 0.4× 29 1.5k
Fabrizio Artioli 456 0.7× 184 0.4× 142 0.4× 319 1.1× 93 0.4× 48 912
Jennifer Oliver 598 1.0× 130 0.3× 101 0.3× 204 0.7× 121 0.6× 31 1.4k
Mary A. Simmonds 264 0.4× 118 0.3× 245 0.7× 161 0.6× 271 1.3× 37 1000
Raffaele Giusti 437 0.7× 156 0.4× 240 0.6× 291 1.0× 377 1.8× 65 1.2k
Arati V. Rao 447 0.7× 294 0.7× 160 0.4× 173 0.6× 28 0.1× 57 1.2k
Francesco Rosetti 640 1.0× 132 0.3× 117 0.3× 438 1.5× 74 0.4× 23 1.1k
Ian G. Kerr 592 1.0× 115 0.3× 153 0.4× 175 0.6× 131 0.6× 37 1.3k

All Works

Loading papers...

Rankless by CCL
2026